Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Those are the types of clues Eli Lillys CEO, David Ricks, says his company will pursue next year, testing whether its GLP-1 drug, tirzepatide (called Mounjaro for diabetes treatment, and Zepbound for weight loss), could help with addiction to alcohol, nicotine, and other things we dont think about [as being] connected to weight. In comments he made in December, Ricks said the drugs might be anti-hedonicsmeaning they counteract our hedonistic pursuit of pleasure, be it from food, alcohol, or drugs
Based on what Im seeing, here are five product areas I believe will surge commercially, whether we like it or not: Meal Replacements + protein shakes: Convenient, portioned, protein-heavy
While it may be tempting to get a quick and, some would argue, easy tan by simply injecting MT2, there's still a lot we don't know about how it affects the body
The aforementioned trial also noted a significant increase in skin thickness in both males and females
GCGR signaling in hepatocytes activates adenylyl cyclase, increasing cAMP and driving glycogenolysis, gluconeogenesis, and critically, hepatic fatty acid oxidation via CPT1a upregulation
US$ 20.71
US$ 21.98
US$ 23.56
US$ 28.55
US$ 27.26
